Neptune Technologies & Bioressources Inc. Audio Webcast and Conference Call Notification for October 17, 2006 at 4:30pm (ET)

CALGARY, Oct. 11 /CNW/ - Notification of Clinical and Business Update

Neptune Technologies & Bioressources Inc., (TSX.V: NTB) Clinical and Business Update Presentation with Tina Sampalis, Vice-President, R&D Business Development

October 17, 2006 at 4:30pm (ET)

To listen to this event, please visit using your web browser:

To join the conference call please dial: 1-800-814-4890 or 416-644-3416

For a complete listing of upcoming and archived Webcasts available through CNW Group, click on the Webcasting icon at the CNW Group Website at http://www.newswire.ca/webcast

CNW's Webcasting is consistent with Market Regulation Services (RS) initiatives to broaden investor access through the use of new technology.

Neither NASDAQ nor TSX venture exchange accepts responsibility for the adequacy or accuracy of this press release.

Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc.
Acasti Pharma Inc.
Toni Rinow, Ph.D., MBA
Corporate Development & Investor Relations
(450) 687-2262
This e-mail address is being protected from spambots, you need JavaScript enabled to view it

# # #

Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports filed with the Securities and Exchange Commission and the Canadian securities commissions.